Gunnel Sundén has 30 years experience of  pharmaceutical research at AstraZeneca. She had a position for 8 years as Medicinal Chemistry Team Leader for the Losec follow-up project (including Nexium) and for part of the time she was Preclinical Leader. After being responsible for the patent portfolios in several projects she took up a position as Scientific Patent Advisor, first in Discovery and then the corresponding position in CVS/GI Development, focused on Patent Strategies for both New Chemical Entity projects and the related Life Cycle Management opportunities.


anita Anita Skeppstedt (M.Sc, LLM) is a European Patent Attorney with 15 years of experience from working in  patent departments in industry, both with consumer products and pharmaceuticals. Anita has  worked for several years as a consultant in private practice, and as an examiner at the Swedish Patent Office. Currently, Anita is running her own consultancy company, Servanda Patent Consulting.


Ingemar S new. Ingemar Starke held a position as Medicinal Chemist at AstraZeneca for over 30 years. As a chemistry leader he has been responsible for identifying novel compounds as candidates in drug discovery projects. This has led to several clinical candidates with  some of them currently in the late clinical research phase.